MLAB

Mesa Laboratories Inc

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$80mEST30-Sep-2610-Q filed 09-Nov-26
Remaining authorization$62mEST30-Sep-2610-Q filed 09-Nov-26
Program expiry31-Dec-2830-Sep-2610-Q filed 09-Nov-26
Repurchased last quarter$030-Sep-2610-Q filed 09-Nov-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
04-Nov-26$40m$40mEST31-Dec-28On November 4, 2026, the Board of Directors terminated the Company’s existing share repurchase program, which was authorized in 2005, and authorized a new program to repurchase up to $40.0 million of the Company’s common stock.10-Q filed 09-Nov-26
07-Nov-05$40mEST
300,000 sh
$22mEST
162,486 sh left
n/aBoard of Directors adopted a share repurchase plan which allows for the repurchase of up to 300,000 of our common shares; however, no shares have been purchased under the plan in any period presented herein. This plan will continue until the maximum is reached or the plan is terminated by further action of the Board of Directors.10-Q filed 09-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. May ’26
  3. ≈$958.3k
    Jun ’26
  4. Jul ’26
  5. Aug ’26
  6. ≈$0
    Sep ’26
Month endedSharesWithheld & otherAvg price≈ ValueSource
30-Sep-260——$010-Q filed 09-Nov-26
31-Aug-260——$010-Q filed 09-Nov-26
31-Jul-260——$010-Q filed 09-Nov-26
30-Jun-2610,12510,125$94.65$958.3k10-Q filed 10-Aug-26
Filings through 30-Sep-26· checked 17-Nov-26